Epidemiological and preclinical studies propose that metformin, a first-line drug for type-2 diabetes, exerts direct antitumor activity. Although several clinical trials are ongoing, the molecular mechanisms of this effect are unknown. Here we show that chloride intracellular channel-1 (CLIC1) is a direct target of metformin in human glioblastoma cells. Metformin exposure induces antiproliferative effects in cancer stem cell-enriched cultures, isolated from three individual WHO grade IV human glioblastomas. These effects phenocopy metformin-mediated inhibition of a chloride current specifically dependent on CLIC1 functional activity. CLIC1 ion channel is preferentially active during the G1-S transition via transient membrane insertion. Metformin inhibition of CLIC1 activity induces G1 arrest of glioblastoma stem cells. This effect was time-dependent, and prolonged treatments caused antiproliferative effects also for low, clinically significant, metformin concentrations. Furthermore, substitution of Arg29 in the putative CLIC1 pore region impairs metformin modulation of channel activity. The lack of drugs affecting cancer stem cell viability is the main cause of therapy failure and tumor relapse. We identified CLIC1 not only as a modulator of cell cycle progression in human glioblastoma stem cells but also as the main target of metformin's antiproliferative activity, paving the way for novel and needed pharmacological approaches to glioblastoma treatment.

Metformin repositioning as antitumoral agent : selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current / M. Gritti, R. Würth, M. Angelini, F. Barbieri, M. Peretti, E. Pizzi, A. Pattarozzi, E. Carra, R. Sirito, A. Daga, P.M.G. Curmi, M. Mazzanti, T. Florio. - In: ONCOTARGET. - ISSN 1949-2553. - 5:22(2014 Nov 30), pp. 11252-11268. [10.18632/oncotarget.2617]

Metformin repositioning as antitumoral agent : selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current

M. Gritti
Primo
;
M. Angelini;M. Peretti;E. Pizzi;M. Mazzanti
Penultimo
;
2014-11-30

Abstract

Epidemiological and preclinical studies propose that metformin, a first-line drug for type-2 diabetes, exerts direct antitumor activity. Although several clinical trials are ongoing, the molecular mechanisms of this effect are unknown. Here we show that chloride intracellular channel-1 (CLIC1) is a direct target of metformin in human glioblastoma cells. Metformin exposure induces antiproliferative effects in cancer stem cell-enriched cultures, isolated from three individual WHO grade IV human glioblastomas. These effects phenocopy metformin-mediated inhibition of a chloride current specifically dependent on CLIC1 functional activity. CLIC1 ion channel is preferentially active during the G1-S transition via transient membrane insertion. Metformin inhibition of CLIC1 activity induces G1 arrest of glioblastoma stem cells. This effect was time-dependent, and prolonged treatments caused antiproliferative effects also for low, clinically significant, metformin concentrations. Furthermore, substitution of Arg29 in the putative CLIC1 pore region impairs metformin modulation of channel activity. The lack of drugs affecting cancer stem cell viability is the main cause of therapy failure and tumor relapse. We identified CLIC1 not only as a modulator of cell cycle progression in human glioblastoma stem cells but also as the main target of metformin's antiproliferative activity, paving the way for novel and needed pharmacological approaches to glioblastoma treatment.
Antitumoral activity; Cancer stem cells; CLIC1; Human glioblastoma; Metformin
Settore BIO/09 - Fisiologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
2617-32264-5-PB.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 5.43 MB
Formato Adobe PDF
5.43 MB Adobe PDF Visualizza/Apri
oncotarget-05-11252.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 4.89 MB
Formato Adobe PDF
4.89 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/243259
Citazioni
  • ???jsp.display-item.citation.pmc??? 60
  • Scopus 90
  • ???jsp.display-item.citation.isi??? 83
social impact